I'd like to open an account http://oscarbohorquez.com/bio/#processes generic wellbutrin pulled by fda Cubist had been cited as one of the most likely buyers forOptimer. Even before Optimer began a sale process, Cubist hadoffered to buy the company for $20 per share, two peoplefamiliar with the matter told Reuters in May. Optimer had turneddown that offer, the people said.